The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•6 May 2026•

1 min read

High Tide Achieves Record Medical Cannabis Sales in Germany for Q2

Key Facts

1High Tide's subsidiary Remexian sold a record 7.6 tonnes of medical cannabis in the German market during the second fiscal quarter.

High Tide Inc. has announced that its German subsidiary, Remexian Pharma GmbH, achieved its highest quarterly distribution volume to date. The company sold a record 7.6 tonnes of medical cannabis in the German market during the second fiscal quarter ended April 30, 2026. This record volume reflects High Tide's accelerating market leadership and strategic expansion within the German medical cannabis sector. These preliminary figures underscore the success of the company's international growth strategy in key European markets. The surge in distribution volume is expected to strengthen the company's market position amid rising demand in the region. Investors are closely monitoring how these operational milestones will translate into overall financial performance in upcoming earnings reports.

Sources: